After the company made sequential improvement in the third quarter, a recent government pricing report could signal trouble for the fashion brand's fourth quarter.
No, it wasn't Wednesday's investor presentation.
The company is raising cash, and the market isn't happy.
Investors are worried about the biotech raising cash.
Promising preclinical data and the acquisition of another small biotech continued to generate enthusiasm among investors.
Investors cheered a return to same-store sales growth and a permanent CEO appointment today.
A weak quarter and a disappointing outlook for the holiday period pushed the stock down.
There was another quarterly miss driven by weakness in a newly acquired business.
D'oh! GameStop just cut its guidance by more than $1 a share.
An earnings meet and a guidance beat send Photronics stock up at the speed of light.
Painful fourth-quarter guidance left shares of the networking technology leader reeling last month.
The market wasn't pleased with decelerating top-line growth.
The freelancer platform is looking to invest more toward driving sustained growth.
The CEO is resigning, and Q4 earnings loom.
A partnership with Grubhub is hurting same-Shack sales in the near term.
The company is raising more money from investors to support development of late-stage drugs.
The fitness center chain benefited from a strong quarterly report, new international expansion plans, and an accelerated stock repurchase plan.
Solid data from the biggest blood disease meeting of the year has the biotech flying high.
The convenience-store operator missed the mark in its fiscal second quarter, despite reporting strong earnings growth.
Investors didn't like the preliminary results from an early-stage study.